Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases
Cerenome will present REYOBIQ multidose research and host a symposium on CNS cancer diagnosis and treatment at the 2026 SNO Annual Meeting.